In vitro reconstitution of mevalonate pathway and targeted engineering of farnesene overproduction in Escherichia coli
暂无分享,去创建一个
Tiangang Liu | Xiaofang Zhong | Zixin Deng | Mengzhu Hu | Z. Deng | Tiangang Liu | Fayin Zhu | Lei Lu | Fayin Zhu | Xiaofang Zhong | Lei Lu | Mengzhu Hu
[1] Jay D. Keasling,et al. Production of amorphadiene in yeast, and its conversion to dihydroartemisinic acid, precursor to the antimalarial agent artemisinin , 2012, Proceedings of the National Academy of Sciences.
[2] Farren J. Isaacs,et al. Programming cells by multiplex genome engineering and accelerated evolution , 2009, Nature.
[3] C. Poulter,et al. Zinc is an essential cofactor for type I isopentenyl diphosphate:dimethylallyl diphosphate isomerase. , 2003, Journal of the American Chemical Society.
[4] C. Khosla,et al. Quantitative analysis and engineering of fatty acid biosynthesis in E. coli. , 2010, Metabolic engineering.
[5] P. León,et al. The plastidial MEP pathway: unified nomenclature and resources. , 2008, Trends in plant science.
[6] J. Keasling,et al. Engineering dynamic pathway regulation using stress-response promoters , 2013, Nature Biotechnology.
[7] J. Keasling,et al. Application of targeted proteomics to metabolically engineered Escherichia coli , 2012, Proteomics.
[8] J. Goldstein,et al. Regulation of the mevalonate pathway , 1990, Nature.
[9] J. Keasling,et al. Engineering a mevalonate pathway in Escherichia coli for production of terpenoids , 2003, Nature Biotechnology.
[10] H. Sahm,et al. Isoprenoid biosynthesis in bacteria: a novel pathway for the early steps leading to isopentenyl diphosphate. , 1993, The Biochemical journal.
[11] J. Keasling,et al. Microbial engineering for the production of advanced biofuels , 2012, Nature.
[12] U. Stahl,et al. Overexpression of a cytosolic hydroxymethylglutaryl-CoA reductase leads to squalene accumulation in yeast , 1998, Applied Microbiology and Biotechnology.
[13] Keith E. J. Tyo,et al. Terpenoids: opportunities for biosynthesis of natural product drugs using engineered microorganisms. , 2008, Molecular pharmaceutics.
[14] Eui-Sung Choi,et al. Metabolic engineering of Escherichia coli for α-farnesene production. , 2011, Metabolic engineering.
[15] Jay D. Keasling,et al. Identification and microbial production of a terpene-based advanced biofuel , 2011, Nature communications.
[16] Gabriel C. Wu,et al. Synthetic protein scaffolds provide modular control over metabolic flux , 2009, Nature Biotechnology.
[17] Jay D Keasling,et al. Metabolic engineering of microbial pathways for advanced biofuels production. , 2011, Current opinion in biotechnology.
[18] W. R. Farmer,et al. Improving lycopene production in Escherichia coli by engineering metabolic control , 2000, Nature Biotechnology.
[19] J. Griffiths,et al. A sensitive mass spectrometric method for hypothesis-driven detection of peptide post-translational modifications: multiple reaction monitoring-initiated detection and sequencing (MIDAS) , 2009, Nature Protocols.
[20] J. Keasling,et al. High-level semi-synthetic production of the potent antimalarial artemisinin , 2013, Nature.
[21] Xueli Zhang,et al. Engineering central metabolic modules of Escherichia coli for improving β-carotene production. , 2013, Metabolic engineering.
[22] Zengyi Shao,et al. DNA assembler, an in vivo genetic method for rapid construction of biochemical pathways , 2008, Nucleic acids research.
[23] J. Keasling,et al. High-throughput metabolic engineering: advances in small-molecule screening and selection. , 2010, Annual review of biochemistry.
[24] D. G. Gibson,et al. Enzymatic Assembly of Overlapping DNA Fragments , 2011, Methods in Enzymology.
[25] Tiangang Liu,et al. In vitro reconstitution and steady-state analysis of the fatty acid synthase from Escherichia coli , 2011, Proceedings of the National Academy of Sciences.
[26] Yinjie J. Tang,et al. Central metabolic responses to the overproduction of fatty acids in Escherichia coli based on 13C‐metabolic flux analysis , 2014, Biotechnology and bioengineering.
[27] Brian F. Pfleger,et al. Application of Functional Genomics to Pathway Optimization for Increased Isoprenoid Production , 2008, Applied and Environmental Microbiology.
[28] J. Rabinowitz,et al. Absolute Metabolite Concentrations and Implied Enzyme Active Site Occupancy in Escherichia coli , 2009, Nature chemical biology.
[29] Jay D. Keasling,et al. High-Level Production of Amorpha-4,11-Diene, a Precursor of the Antimalarial Agent Artemisinin, in Escherichia coli , 2009, PloS one.
[30] J. Rabinowitz,et al. Absolute quantitation of intracellular metabolite concentrations by an isotope ratio-based approach , 2008, Nature Protocols.
[31] J. Keasling,et al. Targeted proteomics for metabolic pathway optimization: application to terpene production. , 2011, Metabolic engineering.
[32] C. You,et al. Simple Cloning via Direct Transformation of PCR Product (DNA Multimer) to Escherichia coli and Bacillus subtilis , 2011, Applied and Environmental Microbiology.
[33] J. Keasling,et al. Biosynthesis of plant isoprenoids: perspectives for microbial engineering. , 2009, Annual review of plant biology.
[34] Keith E. J. Tyo,et al. Isoprenoid Pathway Optimization for Taxol Precursor Overproduction in Escherichia coli , 2010, Science.
[35] Gregory Stephanopoulos,et al. Construction of lycopene-overproducing E. coli strains by combining systematic and combinatorial gene knockout targets , 2005, Nature Biotechnology.
[36] Bruce D. Whitaker,et al. Cloning and functional expression of an (E,E)-α-farnesene synthase cDNA from peel tissue of apple fruit , 2004, Planta.